Find Diphenylpyraline manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

MARKET PLACE

0

API

0

FDF

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Canada

Canada

0

Australia

Australia

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 147-20-6, Hispril, Diphenylpyrilene, Allergen, Diphenylpyralamine, Lyssipoll
Molecular Formula
C19H23NO
Molecular Weight
281.4  g/mol
InChI Key
OWQUZNMMYNAXSL-UHFFFAOYSA-N
FDA UNII
33361OE3AV

Diphenylpyraline
Diphenylpyraline is an antihistamine. Antihistamines used in the treatment of allergy act by competing with histamine for H 1-receptor sites on effector cells. Antihistamines prevent, but do not reverse, responses mediated by histamine alone. Antihistamines antagonize, in varying degrees, most of the pharmacological effects of histamine, including urticaria and pruritus.
1 2D Structure

Diphenylpyraline

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-benzhydryloxy-1-methylpiperidine
2.1.2 InChI
InChI=1S/C19H23NO/c1-20-14-12-18(13-15-20)21-19(16-8-4-2-5-9-16)17-10-6-3-7-11-17/h2-11,18-19H,12-15H2,1H3
2.1.3 InChI Key
OWQUZNMMYNAXSL-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CN1CCC(CC1)OC(C2=CC=CC=C2)C3=CC=CC=C3
2.2 Other Identifiers
2.2.1 UNII
33361OE3AV
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 4-diphenylmethoxy-1-methylpiperidine

2. Diphenylpyraline Hydrochloride

3. Diphenylpyraline Maleate (2:1)

4. Lergobine

2.3.2 Depositor-Supplied Synonyms

1. 147-20-6

2. Hispril

3. Diphenylpyrilene

4. Allergen

5. Diphenylpyralamine

6. Lyssipoll

7. Belfene

8. Dayfen

9. Histryl

10. Histyn

11. Mepiben

12. Neargal

13. 4-(diphenylmethoxy)-1-methylpiperidine

14. 4-(benzhydryloxy)-1-methylpiperidine

15. Difenilpiralina

16. Diphenylpyralinum

17. 1-methyl-4-piperidyl Benzhydryl Ether

18. An 1041

19. 4-benzhydryloxy-1-methylpiperidine

20. Diphenylpyraline (inn)

21. 4-(benzhydryloxy)-n-methylpiperidine

22. Piperidine, 4-(diphenylmethoxy)-1-methyl-

23. Chembl1492

24. 4-diphenylmethoxy-1-methylpiperidine

25. N-methylpiperidyl-(4)-benzhydrylaether Salzsauren Salze

26. P 253

27. 1-methyl-4-hydroxypiperidine Benzhydryl Ether

28. Chebi:59788

29. 33361oe3av

30. 4-benzhydryloxy-1-methyl-piperidine

31. Hystryl

32. Diphenylpyraline [inn]

33. Diphenylpyraline [inn:ban]

34. Difenilpiralina [inn-spanish]

35. Diphenylpyralinum [inn-latin]

36. Nsc61825

37. Ncgc00016395-01

38. Cas-132-18-3

39. Einecs 205-686-7

40. Brn 0245467

41. Unii-33361oe3av

42. N-methylpiperidyl-(4)-benzhydrylaether Salzsauren Salze [german]

43. Diafen (salt/mix)

44. Spectrum_001002

45. 4-[(diphenylmethyl)oxy]-1-methylpiperidine

46. Prestwick0_000707

47. Prestwick1_000707

48. Prestwick2_000707

49. Prestwick3_000707

50. Spectrum2_000982

51. Spectrum3_000401

52. Spectrum4_000521

53. Spectrum5_000917

54. Nciopen2_007716

55. Oprea1_289175

56. Bspbio_000893

57. Bspbio_001922

58. Diphenylpyraline [mi]

59. Kbiogr_001121

60. Kbioss_001482

61. 5-21-01-00053 (beilstein Handbook Reference)

62. Divk1c_000851

63. Schembl119077

64. Spbio_001043

65. Spbio_002814

66. Bpbio1_000983

67. Gtpl7165

68. Diphenylpyraline [vandf]

69. Dtxsid3022952

70. Kbio1_000851

71. Kbio2_001482

72. Kbio2_004050

73. Kbio2_006618

74. Kbio3_001142

75. Zinc56643

76. Diphenylpyraline [who-dd]

77. Ninds_000851

78. Bdbm50241333

79. N-methyl-4-(benzhydryloxy)piperidine

80. Akos015889312

81. Ac-9855

82. Db01146

83. Idi1_000851

84. Ncgc00016395-02

85. Ncgc00016395-03

86. Ncgc00178908-01

87. Ncgc00178908-02

88. 4-(diphenylmethoxy)-1-(methyl)piperidine

89. Sbi-0051354.p003

90. Hy-107431

91. Ab00053461

92. Cs-0028462

93. Ft-0657213

94. D07862

95. Ab00053461_14

96. Ab00053461_15

97. A808623

98. L001180

99. Piperidine, 4-(diphenylmethoxy)-1-methyl

100. Q411150

101. Brd-k22936972-003-05-3

102. Brd-k22936972-003-15-2

2.4 Create Date
2005-03-25
3 Chemical and Physical Properties
Molecular Weight 281.4 g/mol
Molecular Formula C19H23NO
XLogP33.9
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count2
Rotatable Bond Count4
Exact Mass281.177964357 g/mol
Monoisotopic Mass281.177964357 g/mol
Topological Polar Surface Area12.5 Ų
Heavy Atom Count21
Formal Charge0
Complexity268
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

For use in the treatment of allergic rhinitis, hay fever, and allergic skin disorders.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Diphenylpyraline is an antihistamine that prevents, but does not reverse, responses mediated by histamine alone. Diphenylpyraline antagonizes most of the pharmacological effects of histamine, including urticaria and pruritus. Also, diphenylpyraline may exhibit anticholinergic actions (as do most of the antihistamines) and may thus provide a drying effect on the nasal mucosa.


5.2 ATC Code

R - Respiratory system

R06 - Antihistamines for systemic use

R06A - Antihistamines for systemic use

R06AA - Aminoalkyl ethers

R06AA07 - Diphenylpyraline


5.3 Absorption, Distribution and Excretion

Absorption

Well absorbed after oral administration.


5.4 Metabolism/Metabolites

Hepatic


5.5 Mechanism of Action

Antihistamines such as diphenylpyraline used in the treatment of allergy act by competing with histamine for H1-receptor sites on effector cells. This reduces the effects of histamine, leading to a temporary reduction of allergy symptoms.


Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty